Candida Colonization in Urine Samples of ICU Patients: Determination of Etiology, Antifungal Susceptibility Testing and Evaluation of Associated Risk Factors

Mycopathologia

Volumn 174, Issue 2, 2012, Pages 149-155

  Singla, Nidhi ^a   Gulati, Neelam ^a   Kaistha, Neelam ^a   Chander, Jagdish ^a  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Candida colonization; ICU; Risk factors; Trichosporon species

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDA; CANDIDIASIS; CLASSIFICATION; DRUG EFFECT; FEMALE; HUMAN; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; RISK FACTOR; TRICHOSPORON; TRICHOSPORONOSIS; URINE;

ADOLESCENT; ADULT; AGED; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; FEMALE; FLUCONAZOLE; HUMANS; INTENSIVE CARE UNITS; ITRACONAZOLE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RISK FACTORS; TRICHOSPORON; TRICHOSPORONOSIS; URINE; YOUNG ADULT;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS;

EID: 84864289441     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-011-9514-7     Document Type: Article

References (15)

1. Carvalho M, Guimaraes CM, Mayor JR Jr, Bordignon GPF, Queiroz-Telles F. Hospital associated fungiuria: analysis of risk factors, clinical presentation and outcome. Braz J Infect Dis. 2001; 5: 313-8.
2. Paul N, Mathai E, Abraham OC, Mathai D. Emerging microbiological trends in candiduria. Clin Infect Dis. 2004; 39: 1743-4.
3. Febre N, Silva V, Medeiros EAS, Wey SB, Colombo AL, Fischman O. Microbiological characteristics of yeasts isolated from urinary tracts of intensive care unit patients undergoing urinary catheterization. J Clin Microbiol. 1999; 37: 1584-6.
4. Collee JG, Duguid JP, Fraser AG, Marmion BP, Simmons A. Laboratory strategy in the diagnosis of infective syndromes. In: Collee JG, Fraser AG, Marmion BP, Simmons A, editors. Mackie and McCartney: practical medical microbiology. 14th ed. Edinburgh: Churchill Livingstone; 1996. p. 53-94.
5. Kurtzman CP, Fell JW. The yeasts: a taxonomic study. 4th ed. New York: Elsevier; 1998. p. 891-947.
6. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeast. CLSI M27-A3 document. Wayne, Pa; 2008.
7. Sobel JD. Management of asymptomatic candiduria. Int J Antimicrob Agents. 1999; 11: 285-8.
8. da Silva EH, da Silva RL, Matsumoto FE, Auler ME, Giudice MC, Moreira D, et al. Candiduria in a public hospital of Sao Paulo (1999-2004): characteristics of the yeast isolates. Rev Inst Med Trop Sao Paulo. 2007; 49: 349-53.
9. Bukhary ZA. Candiduria: a review of clinical significance and management. Saudi J Kidney Dis Transplant. 2008; 19: 350-60.
10. Guler S, Ural O, Findik D, Arslan U. Risk factors for nosocomial candiduria. Saudi Med J. 2006; 27: 1706-10.
11. Alvarez-Lerma F, Nolla-Sallas J, Palomar M, Jorda R, Carrasco N, Babillo F. Candiduria in critically ill patients admitted to intensive care medical units. Intern Care Med. 2003; 29: 1069-76.
12. Kauffman CA, Vazquez JA, Sobel JD, Gallis HA, McKinsey DS, Karchmer AW, et al. Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis. 2000; 30: 14-8.
13. Passos XS, Sales WS, Maciel PJ, Costa CR, Miranda KC, de Aquino Lemos J, et al. Candida colonization in intensive care unit patients' urine. Mem Inst Oswaldo Cruz. 2005; 100: 925-8.
14. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, et al. Guidelines for treatment of candidiasis. Clin Infect Dis. 2004; 38: 161-9.
15. Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009; 48: 503-35.